JAMA oncology, 2374-2437

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. Determining the Appropriate Risk-Adapted Screening Age for Familial Breast Cancer-Reply

    Mahdi Fallah, Trasias Mukama & Elham Kharazmi, 2020, I : JAMA oncology. 6, 6, s. 934-935

    Forskningsoutput: TidskriftsbidragLetter

  3. 2019
  4. Risk-Adapted Starting Age of Screening for Relatives of Patients with Breast Cancer

    Trasias Mukama, Elham Kharazmi, Xu Xing, Kristina Sundquist, Jan Sundquist, Hermann Brenner & Mahdi Fallah, 2019 nov, I : JAMA oncology.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Association of Immune Marker Changes with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

    Ola Landgren, Jonathan N. Hofmann, Charlene M. McShane, Loredana Santo, Malin Hultcrantz, Neha Korde, Sham Mailankody, DIckran Kazandjian, Kazunori Murata, Katie Thoren, Lakshmi Ramanathan, Ahmet Dogan, Even Rustad, Sydney X. Lu, Theresia Akhlaghi, Sigurdur Y. Kristinsson, Magnus Björkholm, Sean Devlin, Mark P Purdue, Ruth M. Pfeiffer & 1 andra, Ingemar Turesson, 2019 jul 18, I : JAMA oncology.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2018
  7. Association of statin usewith overall and cancer survival

    Thomas P. Ahern, Signe Borgquist & Deirdre P. Cronin-Fenton, 2018 jul 1, I : JAMA oncology. 4, 7, s. 1015-1016

    Forskningsoutput: TidskriftsbidragLetter

  8. Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer a secondary analysis of a randomized clinical trial

    Andrew J. Armstrong, Aseem Anand, Lars Edenbrandt, Eva Bondesson, Anders Bjartell, Anders Widmark, Cora N. Sternberg, Roberto Pili, Helen Tuvesson, Örjan Nordle, Michael A. Carducci & Michael J. Morris, 2018 jul 1, I : JAMA oncology. 4, 7, s. 944-951 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study

    Mihajlo B Jakovljevic & Global Burden of Disease Cancer Collaboration Global Burden of Disease Cancer Collaboration, 2018 jun 2, I : JAMA oncology. 16 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016

    Andrew J Cowan, Christine Allen, Aleksandra Barac, Huda Basaleem, Isabela Bensenor, Maria Paula Curado, Kyle Foreman, Rahul Gupta, James Harvey, H Dean Hosgood, Mihajlo Jakovljevic, Yousef Khader, Shai Linn, Deepesh Lad, Lorenzo Mantovani, Vuong Minh Nong, Ali Mokdad, Mohsen Naghavi, Maarten Postma, Gholamreza Roshandel & 10 andra, Katya Shackelford, Mekonnen Sisay, Cuong Tat Nguyen, Tung Thanh Tran, Bach Tran Xuan, Kingsley Nnanna Ukwaja, Stein Emil Vollset, Elisabete Weiderpass, Edward N Libby & Christina Fitzmaurice, 2018 maj 16, I : JAMA oncology. 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Assessment of Late Mortality Risk after Allogeneic Blood or Marrow Transplantation Performed in Childhood

    Anna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, Kevin Battles, Ravi Bhatia, Liton Francisco, Lindsey Hageman, Michelle Kung, Emily Ness, Mariel Parman, Donna Salzman, Aman Wadhwa, Jeanette Falck Winther, Joseph Rosenthal, Stephen J. Forman, Daniel J. Weisdorf, Saro H. Armenian, Mukta Arora & Smita Bhatia, 2018, I : JAMA oncology. 4, 12, e182453.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review

    Christopher Parker, Valerie Lewington, Neal Shore, Clemens Kratochwil, Moshe Levy, Ola Lindén, Walter Noordzij, Jae Park & Fred Saad, 2018, I : JAMA oncology.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  13. 2017
  14. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden

    Stacy Loeb, Yasin Folkvaljon, Caitlin Curnyn, David Robinson, Ola Bratt & Pär Stattin, 2017 okt 1, I : JAMA oncology. 3, 10, s. 1393-1398 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study

    Mihajlo (Michael) Jakovljevic & Global Burden of Disease Cancer Collaboration Global Burden of Disease Cancer Collaboration, 2017 apr 1, I : JAMA oncology. 3, 4, s. 524-548 25 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: An exploratory analysis of a randomized clinical trial

    Heikki Joensuu, Eva Wardelmann, Harri Sihto, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Jörg T Hartmann, Daniel Pink, Silke Cameron, Peter Hohenberger, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Bengt Nilsson, Raija Kallio, Jouni Junnila, Aki Vehtari & Peter Reichardt, 2017, I : JAMA oncology. 3, 5, s. 602-609 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. 2015
  18. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.

    Elin Edda Sigurdardottir, Ingemar Turesson, Sigrun Helga Lund, Ebba K Lindqvist, Sham Mailankody, Neha Korde, Magnus Björkholm, Ola Landgren & Sigurdur Y Kristinsson, 2015, I : JAMA oncology. 1, 2, s. 168-174

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift